Nonlarge, Low Platelet Component Concentration Fraction: A Novel Platelet Component‐Based Screening Marker for Immune Thrombocytopenia
International Journal of Laboratory Hematology · 2026-12 · 48 (6) · 1377-1384
DOI: 10.1111/ijlh.70206 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 26.07.2026. Verfasst von Takuya Chiba und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Central Clinical Laboratory, Iwate Medical University Hospital, Morioka, Japan. Hauptthemen laut MEDLINE: Blood Platelets, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Introduction
The use of automated hematology analyzers for immune thrombocytopenia (ITP) screening has traditionally relied on platelet size‐related indices, including mean platelet volume and immature platelet fraction. The ADVIA 2120i Hematology System calculates nine platelet fractions based on platelet volume (Vol) and refractive index (RI), the latter reflecting intracellular component concentration. This study evaluated the nonlarge, low platelet component concentration fraction (NL‐LPLC%) as a potential ITP‐specific marker.
Methods
We retrospectively analyzed 55 untreated patients with thrombocytopenia (ITP, 23; myelodysplastic syndromes [MDS], 19; aplastic anemia [AA], 13) and 34 healthy controls. The NL‐LPLC% was measured and compared with the reticulated platelet fraction (RP%) and other platelet indices.
Results
Receiver operating characteristic curve analysis revealed that the NL‐LPLC% (RI: < 1.373, Vol: < 20 fL) showed high diagnostic performance for ITP (sensitivity, 91.3%; specificity, 90.6%). In contrast, large, low component platelets (RI: < 1.373, Vol: ≥ 20 fL) showed lower sensitivity (56.5%) and specificity (65.6%). Patients with ITP had a significantly higher RP% than those with MDS and AA ( p < 0.05) but a lower NL‐LPLC% ( p < 0.01). The NL‐LPLC% and RP% showed a strong negative correlation ( r = −0.72, p < 0.01).
Conclusion
The NL‐LPLC% derived from the nine platelet fractions obtained using an ADVIA 2120i Hematology System may serve as a novel screening marker for ITP, emphasizing platelet quality rather than size alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Central Clinical Laboratory, Iwate Medical University Hospital, Morioka, Japan.
- Iwate Saiseikai Nakatsugawa Hospital, Morioka, Japan.
- Department of Laboratory Medicine and Infectious Diseases, Iwate Medical University School of Medicine, Morioka, Japan.
- Department of Hematology, Iwate Prefectural Chubu Hospital, Kitakami, Japan.
- Department of Hematology and Oncology, Division of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan.
ORCID-Profile: Takuya Chiba, Keijiro Suzuki, Shigeki Ito, Tohru Fujiwara
Zitieren
APA
Chiba, T., Suzuki, K., Otsu, A., Kowata, S., Ito, S., & Fujiwara, T. (2026). Nonlarge, Low Platelet Component Concentration Fraction: A Novel Platelet Component‐Based Screening Marker for Immune Thrombocytopenia. International Journal of Laboratory Hematology, 48(6), 1377-1384. https://doi.org/10.1111/ijlh.70206
Vancouver
Chiba T, Suzuki K, Otsu A, Kowata S, Ito S, Fujiwara T. Nonlarge, Low Platelet Component Concentration Fraction: A Novel Platelet Component‐Based Screening Marker for Immune Thrombocytopenia. International Journal of Laboratory Hematology. 2026;48(6):1377-1384. doi:10.1111/ijlh.70206
BibTeX
@article{Chiba2026,
author = {Chiba, Takuya and Suzuki, Keijiro and Otsu, Akihiro and Kowata, Shugo and Ito, Shigeki and Fujiwara, Tohru},
title = {Nonlarge, Low Platelet Component Concentration Fraction: A Novel Platelet Component‐Based Screening Marker for Immune Thrombocytopenia},
journal = {International Journal of Laboratory Hematology},
year = {2026},
volume = {48},
number = {6},
pages = {1377--1384},
doi = {10.1111/ijlh.70206}
}
EUVIMED